Causes of hOCT1-dependent cholangiocarcinoma resistance to sorafenib and sensitization by tumor-selective gene therapy
Keywords:
Multi-tyrosine
Several cancers
Cholangiocarcinoma (CCA)
Mechanisms of chemoresistance
Citation:
Lozano, E. (Elisa); Macias, R. (Rocío); Monte, M.J. (María J.); et al. "Causes of hOCT1-dependent cholangiocarcinoma resistance to sorafenib and sensitization by tumor-selective gene therapy". Hepatology. 70 (4), 2019, 1246 - 1261
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.